Clinical Trial Update: Effects of Blood Letting in Metabolic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trial evaluating the effects of blood letting in metabolic syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Metabolic Syndrome | Phase 1, Phase 2 | Status: COMPLETED